Topoisomerase III-beta protects from immune dysregulation and tumorigenesis
Topoisomerase III-beta (Top3b) reduces nucleic acid torsional stress and intertwining generated during RNA and DNA metabolism while protecting the genome from pathological R-loops, which otherwise result in DNA breakage and genome instability. By studying <i>Top3b</i> knockout mice (<i>Top3b</i>-KO), we find that the loss of Top3b accelerates the development of spontaneous atypical lymphoid hyperplasia and lymphomas arising in spleens and lymph nodes, organs with prominent Top3b expression. Aging <i>Top3b</i>-KO mice also display splenomegaly and systemic immune alterations including neutrophilia and lymphopenia consistent with chronic inflammation. At the molecular level, Top3b deficiency causes genome-wide R-loop accumulation in splenocytes as measured by CUT&Tag sequencing. Increased R-loops are associated with genomic breaks and activation of immune signaling pathways including innate and adaptive immune cell signaling, IL-4 signaling, FAK signaling, and cGAS-STING. In addition, knocking-out <i>Top3b</i> promotes the rapid development of syngeneic EL4 T cell lymphomas. In conclusion, our work implies that Top3b protects from lymphoma, tumorigenesis, and immune dysregulations.
Authors
- Suresh Kumar (ORCID: https://orcid.org/0000-0001-7404-8259)
- Beverly A. Mock (ORCID: https://orcid.org/0000-0003-2479-4549)
- Liton Kumar Saha (ORCID: https://orcid.org/0000-0003-3391-280X)
- Yves Pommier (ORCID: https://orcid.org/0000-0002-3108-0758)
- Laura Bassel (ORCID: https://orcid.org/0000-0003-1684-6839)
- Anjali Dhall (ORCID: https://orcid.org/0000-0002-0400-2084)
- Md Rasel Al Mahmud (ORCID: https://orcid.org/0000-0003-0401-3311)
- Min-Jung Lee (ORCID: https://orcid.org/0000-0003-3943-8133)
- Valentina M. Factor
- N Sato (ORCID: https://orcid.org/0009-0007-1772-3183)
- Hongliang Zhang (ORCID: https://orcid.org/0000-0002-2834-4839)
- Muhammad S. Alam
- Sourav Saha (ORCID: https://orcid.org/0000-0002-0854-5991)
- Shraddha Rastogi (ORCID: https://orcid.org/0000-0003-0680-0407)
- Shuling Zhang (ORCID: https://orcid.org/0009-0006-4314-9691)
- Simone A. Baechler
Institutions
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- Columbia University (US)
Publication Details
- Journal
- Science Advances
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1126/sciadv.ady7028
- Citations
- 1
- Primary Topic
- Cancer therapeutics and mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.81